IBDEI1EG ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,22637,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22637,1,3,0)
;;=3^Merkle Cell CA,Parts of Face,Other
;;^UTILITY(U,$J,358.3,22637,1,4,0)
;;=4^C4A.39
;;^UTILITY(U,$J,358.3,22637,2)
;;=^5001146
;;^UTILITY(U,$J,358.3,22638,0)
;;=C4A.59^^76^974^84
;;^UTILITY(U,$J,358.3,22638,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22638,1,3,0)
;;=3^Merkle Cell CA,Parts of Trunk,Other
;;^UTILITY(U,$J,358.3,22638,1,4,0)
;;=4^C4A.59
;;^UTILITY(U,$J,358.3,22638,2)
;;=^5001150
;;^UTILITY(U,$J,358.3,22639,0)
;;=C4A.8^^76^974^82
;;^UTILITY(U,$J,358.3,22639,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22639,1,3,0)
;;=3^Merkle Cell CA,Overlapping Sites
;;^UTILITY(U,$J,358.3,22639,1,4,0)
;;=4^C4A.8
;;^UTILITY(U,$J,358.3,22639,2)
;;=^5001157
;;^UTILITY(U,$J,358.3,22640,0)
;;=C4A.9^^76^974^88
;;^UTILITY(U,$J,358.3,22640,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22640,1,3,0)
;;=3^Merkle Cell CA,Unspec
;;^UTILITY(U,$J,358.3,22640,1,4,0)
;;=4^C4A.9
;;^UTILITY(U,$J,358.3,22640,2)
;;=^5001158
;;^UTILITY(U,$J,358.3,22641,0)
;;=C84.09^^76^974^93
;;^UTILITY(U,$J,358.3,22641,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22641,1,3,0)
;;=3^Mycosis Fungoides,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,22641,1,4,0)
;;=4^C84.09
;;^UTILITY(U,$J,358.3,22641,2)
;;=^5001630
;;^UTILITY(U,$J,358.3,22642,0)
;;=C84.03^^76^974^96
;;^UTILITY(U,$J,358.3,22642,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22642,1,3,0)
;;=3^Mycosis Fungoides,Intra-Abdominal Lymph Nodes
;;^UTILITY(U,$J,358.3,22642,1,4,0)
;;=4^C84.03
;;^UTILITY(U,$J,358.3,22642,2)
;;=^5001624
;;^UTILITY(U,$J,358.3,22643,0)
;;=C84.06^^76^974^97
;;^UTILITY(U,$J,358.3,22643,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22643,1,3,0)
;;=3^Mycosis Fungoides,Intrapelvic Lymph Nodes
;;^UTILITY(U,$J,358.3,22643,1,4,0)
;;=4^C84.06
;;^UTILITY(U,$J,358.3,22643,2)
;;=^5001627
;;^UTILITY(U,$J,358.3,22644,0)
;;=C84.02^^76^974^98
;;^UTILITY(U,$J,358.3,22644,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22644,1,3,0)
;;=3^Mycosis Fungoides,Intrathoracic Lymph Nodes
;;^UTILITY(U,$J,358.3,22644,1,4,0)
;;=4^C84.02
;;^UTILITY(U,$J,358.3,22644,2)
;;=^5001623
;;^UTILITY(U,$J,358.3,22645,0)
;;=C84.04^^76^974^92
;;^UTILITY(U,$J,358.3,22645,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22645,1,3,0)
;;=3^Mycosis Fungoides,Axilla/Upper Limb Lymph Nodes
;;^UTILITY(U,$J,358.3,22645,1,4,0)
;;=4^C84.04
;;^UTILITY(U,$J,358.3,22645,2)
;;=^5001625
;;^UTILITY(U,$J,358.3,22646,0)
;;=C84.01^^76^974^94
;;^UTILITY(U,$J,358.3,22646,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22646,1,3,0)
;;=3^Mycosis Fungoides,Head/Face/Neck Lymph Nodes
;;^UTILITY(U,$J,358.3,22646,1,4,0)
;;=4^C84.01
;;^UTILITY(U,$J,358.3,22646,2)
;;=^5001622
;;^UTILITY(U,$J,358.3,22647,0)
;;=C84.05^^76^974^95
;;^UTILITY(U,$J,358.3,22647,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22647,1,3,0)
;;=3^Mycosis Fungoides,Inguinal Region/LE Lymph Nodes
;;^UTILITY(U,$J,358.3,22647,1,4,0)
;;=4^C84.05
;;^UTILITY(U,$J,358.3,22647,2)
;;=^5001626
;;^UTILITY(U,$J,358.3,22648,0)
;;=C84.08^^76^974^99
;;^UTILITY(U,$J,358.3,22648,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,22648,1,3,0)
;;=3^Mycosis Fungoides,Multiple Site Lymph Nodes
;;^UTILITY(U,$J,358.3,22648,1,4,0)
;;=4^C84.08
;;^UTILITY(U,$J,358.3,22648,2)
;;=^5001629
;;^UTILITY(U,$J,358.3,22649,0)
;;=C84.07^^76^974^100
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1EG 3768 printed Nov 22, 2024@17:17:18 Page 2
IBDEI1EG ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,22637,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,22637,1,3,0)
+4 ;;=3^Merkle Cell CA,Parts of Face,Other
+5 ;;^UTILITY(U,$J,358.3,22637,1,4,0)
+6 ;;=4^C4A.39
+7 ;;^UTILITY(U,$J,358.3,22637,2)
+8 ;;=^5001146
+9 ;;^UTILITY(U,$J,358.3,22638,0)
+10 ;;=C4A.59^^76^974^84
+11 ;;^UTILITY(U,$J,358.3,22638,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,22638,1,3,0)
+14 ;;=3^Merkle Cell CA,Parts of Trunk,Other
+15 ;;^UTILITY(U,$J,358.3,22638,1,4,0)
+16 ;;=4^C4A.59
+17 ;;^UTILITY(U,$J,358.3,22638,2)
+18 ;;=^5001150
+19 ;;^UTILITY(U,$J,358.3,22639,0)
+20 ;;=C4A.8^^76^974^82
+21 ;;^UTILITY(U,$J,358.3,22639,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,22639,1,3,0)
+24 ;;=3^Merkle Cell CA,Overlapping Sites
+25 ;;^UTILITY(U,$J,358.3,22639,1,4,0)
+26 ;;=4^C4A.8
+27 ;;^UTILITY(U,$J,358.3,22639,2)
+28 ;;=^5001157
+29 ;;^UTILITY(U,$J,358.3,22640,0)
+30 ;;=C4A.9^^76^974^88
+31 ;;^UTILITY(U,$J,358.3,22640,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,22640,1,3,0)
+34 ;;=3^Merkle Cell CA,Unspec
+35 ;;^UTILITY(U,$J,358.3,22640,1,4,0)
+36 ;;=4^C4A.9
+37 ;;^UTILITY(U,$J,358.3,22640,2)
+38 ;;=^5001158
+39 ;;^UTILITY(U,$J,358.3,22641,0)
+40 ;;=C84.09^^76^974^93
+41 ;;^UTILITY(U,$J,358.3,22641,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,22641,1,3,0)
+44 ;;=3^Mycosis Fungoides,Extranodal/Solid Organ Sites
+45 ;;^UTILITY(U,$J,358.3,22641,1,4,0)
+46 ;;=4^C84.09
+47 ;;^UTILITY(U,$J,358.3,22641,2)
+48 ;;=^5001630
+49 ;;^UTILITY(U,$J,358.3,22642,0)
+50 ;;=C84.03^^76^974^96
+51 ;;^UTILITY(U,$J,358.3,22642,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,22642,1,3,0)
+54 ;;=3^Mycosis Fungoides,Intra-Abdominal Lymph Nodes
+55 ;;^UTILITY(U,$J,358.3,22642,1,4,0)
+56 ;;=4^C84.03
+57 ;;^UTILITY(U,$J,358.3,22642,2)
+58 ;;=^5001624
+59 ;;^UTILITY(U,$J,358.3,22643,0)
+60 ;;=C84.06^^76^974^97
+61 ;;^UTILITY(U,$J,358.3,22643,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,22643,1,3,0)
+64 ;;=3^Mycosis Fungoides,Intrapelvic Lymph Nodes
+65 ;;^UTILITY(U,$J,358.3,22643,1,4,0)
+66 ;;=4^C84.06
+67 ;;^UTILITY(U,$J,358.3,22643,2)
+68 ;;=^5001627
+69 ;;^UTILITY(U,$J,358.3,22644,0)
+70 ;;=C84.02^^76^974^98
+71 ;;^UTILITY(U,$J,358.3,22644,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,22644,1,3,0)
+74 ;;=3^Mycosis Fungoides,Intrathoracic Lymph Nodes
+75 ;;^UTILITY(U,$J,358.3,22644,1,4,0)
+76 ;;=4^C84.02
+77 ;;^UTILITY(U,$J,358.3,22644,2)
+78 ;;=^5001623
+79 ;;^UTILITY(U,$J,358.3,22645,0)
+80 ;;=C84.04^^76^974^92
+81 ;;^UTILITY(U,$J,358.3,22645,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,22645,1,3,0)
+84 ;;=3^Mycosis Fungoides,Axilla/Upper Limb Lymph Nodes
+85 ;;^UTILITY(U,$J,358.3,22645,1,4,0)
+86 ;;=4^C84.04
+87 ;;^UTILITY(U,$J,358.3,22645,2)
+88 ;;=^5001625
+89 ;;^UTILITY(U,$J,358.3,22646,0)
+90 ;;=C84.01^^76^974^94
+91 ;;^UTILITY(U,$J,358.3,22646,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,22646,1,3,0)
+94 ;;=3^Mycosis Fungoides,Head/Face/Neck Lymph Nodes
+95 ;;^UTILITY(U,$J,358.3,22646,1,4,0)
+96 ;;=4^C84.01
+97 ;;^UTILITY(U,$J,358.3,22646,2)
+98 ;;=^5001622
+99 ;;^UTILITY(U,$J,358.3,22647,0)
+100 ;;=C84.05^^76^974^95
+101 ;;^UTILITY(U,$J,358.3,22647,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,22647,1,3,0)
+104 ;;=3^Mycosis Fungoides,Inguinal Region/LE Lymph Nodes
+105 ;;^UTILITY(U,$J,358.3,22647,1,4,0)
+106 ;;=4^C84.05
+107 ;;^UTILITY(U,$J,358.3,22647,2)
+108 ;;=^5001626
+109 ;;^UTILITY(U,$J,358.3,22648,0)
+110 ;;=C84.08^^76^974^99
+111 ;;^UTILITY(U,$J,358.3,22648,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,22648,1,3,0)
+114 ;;=3^Mycosis Fungoides,Multiple Site Lymph Nodes
+115 ;;^UTILITY(U,$J,358.3,22648,1,4,0)
+116 ;;=4^C84.08
+117 ;;^UTILITY(U,$J,358.3,22648,2)
+118 ;;=^5001629
+119 ;;^UTILITY(U,$J,358.3,22649,0)
+120 ;;=C84.07^^76^974^100
